catheterization ablation - SportsID
Yahoo Finance: Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S. Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System MassDevice: Adagio Medical wins FDA IDE to expand ventricular ablation study to use next-gen catheter Adagio Medical wins FDA IDE to expand ventricular ablation study to use next-gen catheter Pulse Biosciences, Inc.
Understanding the Context
(Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced enrollment of the first patients in its ... Please provide your email address to receive an email when new articles are posted on . The debate on the use of catheter ablation in patients with atrial fibrillation has intensified among ... Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...